Table 2 Overview of mouse strains used in this study
Mouse strain | Model | Plasma protein concentration (μg μl−1)a | Sourceb |
---|---|---|---|
C57BL/6 | Infectious diseases and diet-induced metabolic pathologies | 20.1 ± 2.06 | BioReclamationIVT |
C57BL/6/CRL | 38.6 ± 1.94 | TCP (Charles River Laboratories, Wilmington, MA, USA) | |
C57BL/6J | 42.3 ± 3.33 | TCP (Jackson Laboratory, Bar Harbor, ME, USA) | |
129S1/SvlmJ | Transgenic and knockout model development and stem cell line production | 42.0 ± 2.32 | TCP |
NOD/SCID/J#1303 | Tumor biology and immunology | 37.8 ± 3.53 | TCP |
BALB/cJ | Infectious diseases and immunology | 39.7 ± 2.30 | TCP |
CD1 | General multipurpose model and mutant production | 45.4 ± 4.94 | TCP |